Norway Awards Lytix Biopharma NOK 12 Million for Tumor Research
The Research Council of Norway awarded Lytix Biopharma NOK 12 million to extend its oncolytic platform to deep-seated tumors.
The Research Council of Norway awarded Lytix Biopharma NOK 12 million to extend its oncolytic platform to deep-seated tumors.